Form DEFA14A USANA HEALTH SCIENCES
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Mark One)
☒ Filed by the Registrant
☐ Filed by a Party other than the Registrant
Check the appropriate box:
| ☐ |
Preliminary Proxy Statement
|
| ☐ |
Confidential, For use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
| ☐ |
Definitive Proxy Statement
|
| ☒ |
Definitive Additional Materials
|
| ☐ |
Soliciting Material Pursuant to § 240.14a-12
|
|
USANA HEALTH SCIENCES, INC.
|
||
|
(Name of Registrant as Specified in its Charter)
|
||
|
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
|
Payment of Filing Fee (Check the appropriate box):
| ☒ |
No fee required.
|
| ☐ |
Fee paid previously with preliminary materials.
|
| ☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays as
currently valid OMB control number.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KBRA Assigns Preliminary Ratings to Upstart Securitization Trust 2026-4
- Genentech Breaks Ground on $750 Million Manufacturing Expansion in Hillsboro, Oregon
- RGC Resources, Inc. Declares Quarterly Dividend
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
